编号：2017-【04】 证券代码：000990 证券简称： 诚志股份 诚志股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|--------------------------|-----------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | 投资者关系活动 | □ | 媒体采访 □业绩说明会 | | 类别 | □ 新闻发布会 | □路演活动 | | | □ 现场参观 | | | | □其他 | | | 参与单位名称及 | 东吴证券 肖雅博 | | | 人员姓名 | 博时基金 陈 鹏 | | | 时间 | 2017 年 12 月 19 | 日 | | 地点 | 会议室 | 北京海淀区清华科技园创新大厦 B 座诚志股份北京管理总部 | | | | | | 上市公司接待人 员姓名 | 公司董事会秘书曹远刚 | | | 投资者关系活动 | 1 | 、公司业绩未来增长点有哪些？ | | 主要内容介绍 | | 去年定增完成后，公司营业收入 ...

证券代码：000990 证券简称：诚志股份 诚志股份有限公司投资者关系活动记录表 | --- | --- | --- | |------------------|--------------------------------|------------------------------------------------------| | | | | | 投资者关系活动类 | √特定对象调研 | □ 分析师会议 | | 别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ | 其他 （请文字说明其他活动内容） | | 参与单位名称及人 | 平安证券股份有限公司 刘永来 | | | 员姓名 | 平安国际融资租赁有限公司 赵丹 | | | 时间 | 2019 年 6 月 5 日 | | | 地点 | 北京创新大厦 B 座 | 16 层会议室 | | 公司接待人员姓名 | 邹勇华、曹远刚 | | | 投资者关系活动主 | 1 、公司产业链延伸介绍 | | | 要内容介绍 | | 诚志股份经过二十年的发展形成了现有的格局， MTO | ...

Company Overview - Chengzhi Co., Ltd. was established in September 2003 with a registered capital of approximately 3.686 billion CNY and occupies an area of 54 hectares. The company has completed multiple production facilities in three phases, with a fourth phase project of 600,000 tons MTO currently under construction [2][3]. Product and Market Position - The company specializes in the production and operation of various gases, co-producing methanol, olefins, and other products, aiming to become a leading industrial gas supplier in China. It has established a complementary industrial chain in the Nanjing Chemical Industrial Park, focusing on resource optimization and cooperative benefits [3][4]. - Chengzhi's main products include industrial gases (synthesis gas, carbon monoxide, hydrogen, etc.) and basic chemical raw materials (ethylene, butanol, etc.), primarily serving large downstream customers within the Nanjing Chemical Industrial Park [3][4]. Sales and Pricing Strategy - Industrial gas products are sold through long-term supply contracts, with pricing based on infrastructure fees and variable gas fees. Liquid chemical product prices are determined by market rates [4]. - Ethylene pricing is primarily referenced against Northeast Asia prices, adjusted monthly considering tariffs, VAT, and logistics costs [4]. Operational Strategy - The company follows a strategy of "binding upstream, stabilizing midstream, and enriching downstream" to ensure raw material supply and explore high-tech, high-value-added product lines. It aims to enhance risk resistance and improve operational efficiency [5]. - Chengzhi emphasizes safe and stable high-load operations, cost reduction, and efficiency improvement, with a focus on completing the 600,000 tons/year MTO project and achieving performance targets for 2018 [5].

编号：2018-【03】 证券代码：000990 证券简称： 诚志股份 诚志股份有限公司投资者关系活动记录表 | --- | --- | --- | |--------------|-------------------------|-------------------------------------------------------------| | | √ | 特定对象调研 □分析师会议 | | 投资者关系活 | □ | 媒体采访 □业绩说明会 | | 动类别 | □ 新闻发布会 | □路演活动 | | | □ 现场参观 | | | | □其他 | | | 参与单位名称 | 华泰证券 庄汀洲 | | | 及人员姓名 | 天风证券 刘树德 | | | | 长盛基金 黄 | 聪 | | | 泰达红利基金 | 孟 杰 | | 时间 | 2018 年 5 月 15 | 日 | | 地点 | | 北京海淀区清华科技园创新大厦 B 座诚志股份北京管理总部会 | | | 议室 | | | 上市公司接待 | | | | 人员姓名 | | 公司副总裁、董事会秘书曹远刚 | | 投资者关系活 | 1 | 、公司今年第 ...

证券代码：000990 证券简称： 诚志股份 编号：2018-【05】 诚志股份有限公司投资者关系活动记录表 | --- | --- | --- | |-----------------------|--------------------------|----------------------------------------------------| | | | | | | √ | 特定对象调研 □分析师会议 | | 投资者关系活动 | □ | 媒体采访 □业绩说明会 | | | □ 新闻发布会 | □路演活动 | | 类别 | □ 现场参观 | | | | □其他 | | | 参与单位名称及 | 浙江华侨财务管理有限公司 | 王渊 郑秀芳 严方 | | 人员姓名 | | | | 时间 | 2018 年 11 月 22 | 日 | | 地点 | 北京创新大厦B座 | 17 层会议室 | | 上市公司接待人 员姓名 | 张喜民、邹勇华、曹远刚 | | | 投资者关系活动 | 一、会议 | | | 主要内容介绍 | 1 、介绍公司基本情况。 | | | | | 诚志股份是清华产业中的重要板块， 1998 ...

证券代码：000990 证券简称：诚志股份 诚志股份有限公司投资者关系活动记录表 编号：2021-【01】 | --- | --- | --- | |---------------------------------|----------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------| | | | | | 投资者关系活动类 | | √特定对象调研 □分析师会议 | | 别 | | □媒体采访 □业绩说 ...

证券代码：000990 证券简称：诚志股份 | --- | --- | --- | |------------------|-------------------------------------------------|--------------------------------------------------------------| | | | 编号： 2021-【03 】 | | 投资者关系活动类 | √特定对象调研 | □ 分析师会议 | | 别 | □ 媒体采访 | □ 业绩说明会 | | | □ 新闻发布会 | □ 路演活动 | | | □ 现场参观 | | | | □ 其他 | （请文字说明其他活动内容） | | 参与单位名称及人 | | 中金公司：裘孝锋、赵启超、肖亚平；海富通基金：宫衍海、 | | 员姓名 | 等三十余家机构的投资经理及行业研究员。 | 刘洋；广发基金：王琪；招商财富：杨瀚；锐意资本：刘翎 | | 时间 | 2021 年 10 月 11 日 | | | 地点 | 电话会议 | | | 公司接待人员姓名 | 副总裁、董事会秘书 诚志生命科技有限公司董事长 | 曹远刚 ...

1 证券代码：000990 证券简称：诚志股份 编号：2022-002 | --- | --- | --- | |------------------|-----------------------------------------------|--------------------------------------------------------------| | | □特定对象调研 | □分析师会议 | | | □媒体采访 □业绩说明会 | | | 投资者关系活动类 | □新闻发布会 □路演活动 | | | 别 | □现场参观 | | | | √其他 诚志股份有限公司 | 2022 年公开发行公司债券交流会 | | | | 东证资管：宗云霄；兴业信托：杨炎临；紫金保险：沈超； | | 参与单位名称及人 | | 江苏银行南分投行：钱浩然；江苏银行南京分行六合支行： | | 员姓名 | 孙磊；杭州银行南京分行：王雪等 及行业研究员。 | 60 余家机构的投资经理 | | 时间 | 2022 年 9 月 21 日 | | | | | | | 地点 | | 南京诚志清洁能源有限公司，线上线下同步 | | ...

[Key Financial Data](index=2&type=section&id=Item%20I.%20Key%20Financial%20Data) Q3 and YTD 2022 performance significantly declined, with substantial drops in net profit and operating cash flow [Key Accounting Data and Financial Indicators](index=2&type=section&id=Item%20(I)%20Key%20Accounting%20Data%20and%20Financial%20Indicators) Q3 and YTD 2022 performance significantly declined, with revenue down 10.66% and net profit attributable to shareholders turning into a loss Key Financial Indicators for Q3 and YTD 2022 | Indicator | Current Period (Q3) | YoY Change in Current Period | YTD (YTD) | YoY Change in YTD | | :--- | :--- | :--- | :--- | :--- | | Operating Revenue (Yuan) | 2,835,821,919.31 | -10.66% | 9,319,553,429.31 | -2.68% | | Net Profit Attributable to Shareholders of Listed Company (Yuan) | -118,466,291.76 | -132.40% | 31,450,819.17 | -97.15% | | Net Profit Attributable to Shareholders of Listed Company (Excluding Non-recurring Items) (Yuan) | -131,646,778.63 | -133.84% | 7,861,788.59 | -99.30% | | Net Cash Flow from Operating Activities (Yuan) | — | — | 1,138,041,162.64 | -34.59% | | Basic Earnings Per Share (Yuan/Share) | -0.0975 | -132.40% | 0.0259 | -97.15% | Key Balance Sheet Data at Period End | Indicator | End of Current Period | End of Prior Year | Change from Prior Year End | | :--- | :--- | :--- | :--- | | Total Assets (Yuan) | 25,311,196,577.61 | 24,447,250,885.01 | 3.53% | | Owners' Equity Attributable to Shareholders of Listed Company (Yuan) | 17,682,309,888.90 | 17,651,704,619.24 | 0.17% | [Non-recurring Gains and Losses Items and Amounts](index=2&type=section&id=Item%20(II)%20Non-recurring%20Gains%20and%20Losses%20Items%20and%20Amounts) Non-recurring gains and losses totaled 13.18 million yuan for the period and 23.59 million yuan YTD, primarily from government subsidies and investment gains Details of Non-recurring Gains and Losses (Unit: Yuan) | Item | Current Period Amount | YTD Amount | | :--- | :--- | :--- | | Gains and Losses from Disposal of Non-current Assets | -582,934.88 | -256,453.92 | | Government Subsidies Included in Current Profit and Loss | 5,165,174.38 | 18,172,648.76 | | Gains and Losses from Changes in Fair Value of Financial Assets/Liabilities Held for Trading, etc | 3,904,138.89 | 3,904,138.89 | | Other Non-operating Income and Expenses | -1,959,023.35 | -3,750,982.21 | | Other Gains and Losses Meeting the Definition of Non-recurring Items | 10,497,790.60 | 10,497,790.60 | | **Total** | **13,180,486.87** | **23,589,030.58** | [Analysis of Changes in Key Financial Indicators and Reasons](index=3&type=section&id=Item%20(III)%20Changes%20in%20Key%20Accounting%20Data%20and%20Financial%20Indicators%20and%20Reasons) Key financial indicators showed significant changes, including increased short-term borrowings and contract liabilities, and over 90% decline in operating profit and net profit - From the beginning of the year to the end of the reporting period, the company's profitability significantly declined, primarily due to a substantial year-on-year increase in raw material prices for main products, significant price reductions for some products, decreased customer demand, and reduced production load[12](index=12&type=chunk) Changes in Key Financial Indicators YTD | Item | Change (%) | Reason for Change | | :--- | :--- | :--- | | **Income Statement Items** | | | | Operating Profit | -91.54% | Raw material prices increased, product prices decreased, demand reduced | | Total Profit | -91.65% | Same as above | | Net Profit Attributable to Parent Company Shareholders | -97.15% | Same as above | | **Cash Flow Statement Items** | | | | Net Cash Flow from Operating Activities | -34.59% | Increased procurement costs | | Net Cash Flow from Investing Activities | -151.01% | Increased net investment | | Net Cash Flow from Financing Activities | 196.28% | Increased bank financing | - At the end of the reporting period, the company's short-term borrowings increased by **30.51%** from the beginning of the year, contract liabilities by **64.25%**, and other current liabilities by **193.36%**, mainly due to increased bank loans, advances from customers, and letter of credit financing[12](index=12&type=chunk) [Shareholder Information](index=4&type=section&id=Item%20II.%20Shareholder%20Information) Details on the company's common shareholder base and top ten shareholders, including major state-owned entities, are provided [Common Shareholder Holdings](index=4&type=section&id=Item%20(I)%20Total%20Number%20of%20Common%20Shareholders%2C%20Number%20of%20Preferred%20Shareholders%20with%20Restored%20Voting%20Rights%2C%20and%20Top%20Ten%20Shareholders%27%20Holdings) The company had 42,097 common shareholders, with the top two holding 29.90% and 15.30% respectively - As of the end of the reporting period, the company had a total of **42,097** common shareholders[16](index=16&type=chunk) Top Ten Shareholders' Holdings | Shareholder Name | Shareholder Nature | Holding Percentage | Number of Shares Held | | :--- | :--- | :--- | :--- | | Chengzhi Kerong Holdings Co., Ltd | State-owned Legal Entity | 29.90% | 374,650,564 | | Tianfu Qingyuan Holdings Co., Ltd | State-owned Legal Entity | 15.30% | 191,677,639 | | Beijing Jinxin Zhuohua Investment Center (Limited Partnership) | Domestic Non-state-owned Legal Entity | 6.56% | 82,240,026 | | Zhongji Jin Investment Asset Management Co., Ltd | Other | 5.55% | 69,498,140 | | Xiao Yanli | Domestic Natural Person | 2.52% | 31,594,692 | [Other Significant Matters](index=5&type=section&id=Item%20III.%20Other%20Significant%20Matters) The company disclosed progress on several significant matters, including major project investments, a subsidiary listing plan, and resolution of a debt dispute - The company plans to invest approximately **4 billion yuan** in a POE (Polyolefin Elastomer) project and **800 million yuan** in an Ultra-High Molecular Weight Polyethylene project through its wholly-owned subsidiary Qingdao Huaqing, both currently in the preliminary approval stage[20](index=20&type=chunk) - The company has initiated preliminary preparations for the spin-off and listing of its controlled subsidiary, Beijing Chengzhi Yonghua Technology Co., Ltd[24](index=24&type=chunk) - The newly constructed Yinhe Road Hydrogen Refueling Station project in Changshu has completed trial production and safety facility acceptance, obtained a hazardous chemical operating license, and is capable of hydrogen refueling[23](index=23&type=chunk) - Regarding the industrial hemp project of its subsidiary Yunnan Hanmeng Pharmaceutical, the company is actively coordinating factory delivery and has completed preparations for trial production[23](index=23&type=chunk) - A consensus has been reached regarding the debt dispute with Ningxia Chengzhi Wansheng Bio, with the counterparty agreeing to installment payments and providing mortgage guarantees[25](index=25&type=chunk) [Quarterly Financial Statements](index=6&type=section&id=Item%20IV.%20Quarterly%20Financial%20Statements) The quarterly financial statements present the consolidated balance sheet, income statement, and cash flow statement, noting significant changes in assets, liabilities, and profitability [Consolidated Balance Sheet](index=6&type=section&id=1.%20Consolidated%20Balance%20Sheet) As of September 30, 2022, total assets were 25.311 billion yuan, up 3.53%, total liabilities were 6.813 billion yuan, up 13.84%, and owners' equity attributable to shareholders was 17.682 billion yuan Key Items from Consolidated Balance Sheet (Unit: Yuan) | Item | September 30, 2022 | December 31, 2021 | | :--- | :--- | :--- | | **Assets** | | | | Total Current Assets | 6,740,608,606.78 | 5,851,559,381.11 | | Total Non-current Assets | 18,570,587,970.83 | 18,595,691,503.90 | | **Total Assets** | **25,311,196,577.61** | **24,447,250,885.01** | | **Liabilities** | | | | Total Current Liabilities | 4,794,798,634.18 | 3,888,942,623.73 | | Total Non-current Liabilities | 2,018,033,804.62 | 2,095,694,229.39 | | **Total Liabilities** | **6,812,832,438.80** | **5,984,636,853.12** | | **Owners' Equity** | | | | Total Owners' Equity Attributable to Parent Company | 17,682,309,888.90 | 17,651,704,619.24 | | Minority Interests | 816,054,249.91 | 810,909,412.65 | | **Total Owners' Equity** | **18,498,364,138.81** | **18,462,614,031.89** | [Consolidated Income Statement (YTD)](index=8&type=section&id=2.%20Consolidated%20Income%20Statement%20from%20Beginning%20of%20Year%20to%20End%20of%20Reporting%20Period) In the first three quarters of 2022, operating revenue was 9.32 billion yuan, down 2.68%; operating profit plummeted 91.54% due to rising costs and falling prices, with net profit attributable to parent company shareholders dropping 97.15% Key Items from Consolidated Income Statement (Jan-Sep 2022 vs Jan-Sep 2021) | Item | Current Period Amount (Yuan) | Prior Period Amount (Yuan) | | :--- | :--- | :--- | | I. Total Operating Revenue | 9,319,553,429.31 | 9,576,671,284.06 | | II. Total Operating Costs | 9,107,393,275.74 | 8,112,556,633.04 | | III. Operating Profit | 118,326,539.59 | 1,398,693,302.47 | | IV. Total Profit | 114,576,237.57 | 1,372,897,320.58 | | V. Net Profit | 110,980,254.37 | 1,139,103,232.71 | | Net Profit Attributable to Parent Company Shareholders | 31,450,819.17 | 1,104,415,324.47 | | Minority Interests Income/Loss | 79,529,435.20 | 34,687,908.24 | | VIII. Basic Earnings Per Share | 0.0259 | 0.9088 | [Consolidated Cash Flow Statement (YTD)](index=10&type=section&id=3.%20Consolidated%20Cash%20Flow%20Statement%20from%20Beginning%20of%20Year%20to%20End%20of%20Reporting%20Period) In the first three quarters of 2022, net cash flow from operating activities was 1.138 billion yuan, down 34.59%; net cash outflow from investing activities expanded 151.01%; and net cash inflow from financing activities was 502 million yuan Key Items from Consolidated Cash Flow Statement (Jan-Sep 2022 vs Jan-Sep 2021) | Item | Current Period Amount (Yuan) | Prior Period Amount (Yuan) | | :--- | :--- | :--- | | Net Cash Flow from Operating Activities | 1,138,041,162.64 | 1,739,969,744.54 | | Net Cash Flow from Investing Activities | -1,359,916,790.50 | -541,781,368.81 | | Net Cash Flow from Financing Activities | 501,988,061.03 | -521,376,066.09 | | Net Increase in Cash and Cash Equivalents | 281,298,825.89 | 676,700,581.14 | [Audit Report Notes](index=11&type=section&id=Item%20(II)%20Audit%20Report) The company's 2022 third-quarter report is unaudited - The company's third-quarter report is unaudited[44](index=44&type=chunk)

Financial Performance - The company's operating revenue for the first half of 2022 was CNY 6,483,731,510, representing a 1.27% increase compared to CNY 6,402,363,245 in the same period last year[27]. - The net profit attributable to shareholders of the listed company decreased by 79.71% to CNY 149,917,110.93 from CNY 738,730,738.74 in the previous year[27]. - The net profit attributable to shareholders after deducting non-recurring gains and losses fell by 80.85% to CNY 139,508,567.22 compared to CNY 728,555,580.07 last year[27]. - The net cash flow from operating activities decreased by 14.46% to CNY 783,457,876.02 from CNY 915,885,671.17 in the same period last year[27]. - Basic earnings per share dropped by 79.70% to CNY 0.1234 from CNY 0.6079 in the previous year[27]. - Total assets increased by 3.57% to CNY 25,318,931,770.12 from CNY 24,447,250,885.01 at the end of the previous year[27]. - The net assets attributable to shareholders of the listed company increased by 0.87% to CNY 17,805,014,960.15 from CNY 17,651,704,619.24 at the end of last year[27]. - The company plans not to distribute cash dividends or issue bonus shares[6]. Operational Challenges - The clean energy business faced significant challenges due to high coal prices and fluctuating global commodity prices, impacting profitability[42]. - The subsidiary Nanjing Chengzhi reported a significant decrease in profitability due to rising costs of raw materials and weak downstream demand, impacting overall performance[91]. - In the first half of 2022, the semiconductor display materials segment faced challenges with decreased demand and product prices, but the subsidiary Shijiazhuang Chengzhi Yonghua successfully launched high-spec products and advanced sales of new TFT LCD projects[43]. Research and Development - Nanjing Chengzhi's R&D investment reached 79 million yuan in the first half of 2022, with 25 projects initiated and 10 patents granted[47]. - Shijiazhuang Chengzhi Yonghua holds 775 total patent applications, with 331 granted, including 113 overseas patents, and was awarded the "2022 High-Value Patent Portfolio Demonstration Unit" title[48]. - Chengzhi Bioengineering is the only global company with complete intellectual property rights for D-ribose, which has seen rapid growth and is widely used in pharmaceuticals and nutrition[49]. Environmental and Social Responsibility - The company is classified as a key pollutant discharge unit, with specific emissions data reported for various pollutants[104]. - The company has implemented several environmental protection facilities, including a secondary AO biochemical treatment device and a dual-membrane water reuse system[108]. - The company reported total emissions of COD at 124.275 tons and ammonia nitrogen at 23.25 tons, exceeding the permitted limits for some pollutants[104]. - The company actively participates in social responsibility initiatives, focusing on education, healthcare, and environmental protection[124]. - The company has committed to rural revitalization efforts, ensuring that no previously lifted households fall back into poverty, maintaining a close connection with local communities[132]. Legal Matters - The company is involved in multiple lawsuits with total amounts at stake of approximately ¥1,282.23 million, ¥1,635.34 million, and ¥1,244.52 million, among others[152]. - The company has ongoing litigation with amounts such as ¥1,877.43 million and ¥1,589.69 million, with some cases resulting in favorable judgments[153]. - The company has reported that certain defendants have been ordered to pay amounts including ¥482.37 million and ¥620.4 million, with some cases involving joint liability for payment[153]. - The company has disclosed that it has not formed any expected liabilities related to the ongoing lawsuits[152]. Governance and Management - The company has established a robust governance structure, ensuring clear responsibilities among the shareholders, board of directors, and management[125]. - The company has implemented risk management measures to control market, liquidity, credit, operational, and legal risks associated with derivative investments[77]. - The company has not encountered any litigation issues during the reporting period[75].